OPRX — OptimizeRx Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyAdventurousSmall CapSuper Stock

Annual cashflow statement for OptimizeRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	0.378	-11.4	-17.6	-20.1	5.13
Depreciation
Deferred Taxes
Non-Cash Items	5.69	16.1	23.5	20	8.44
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-7.31	3.96	-15.5	0.671	-0.398
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	0.726	10.7	-7.24	4.89	18.7
Capital Expenditures	-0.464	-0.243	-0.871	-0.45	0.068
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	-0.022	-57.9	-24.5	—	—
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities	-0.486	-58.2	-25.3	-0.45	0.068
Financing Cash Flow Items	-1.61	0	—	-0.911	-1.15
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	73.9	-19	28.2	-4.91	-8.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	74.2	-66.5	-4.36	-0.472	9.98